Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma × Fulvestrant × Clear all

Sponsor

Conditions

Breast Neoplasms 91 Neoplasms 12 Neoplasm Metastasis 12 Hereditary Sensory and Autonomic Neuropathies 3 Advanced Breast Cancer 3 Recurrence 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Breast Neoplasms, Male 2 Solid Malignancies 1 Recurrent Uterine Corpus Carcinoma 1 Prostatic Neoplasms 1 Neoplasms by Site 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Hyperglycemia 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hormone Receptor Positive Breast Cancer 1 HER2-positive Breast Cancer 1 Estrogen Receptor-positive Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1 Breast Cancer Metastatic 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1 Advanced Breast Carcinoma 1

Interventions

Doxorubicin 30 Ifosfamide 21 pazopanib 17 Gemcitabine 15 Cyclophosphamide 13 pembrolizumab 11 Radiotherapy 11 Docetaxel 10 Sirolimus 9 Filgrastim 9 Vincristine 8 Irinotecan 8 Bevacizumab 8 Sorafenib 7 Etoposide 7 temsirolimus 6 olaratumab 6 eribulin 6 cixutumumab 5 Trabectedin 5 Radiosurgery 5 Radiation 5 Mesna 5 Magnetic Resonance Spectroscopy 5 tazemetostat 4 etoposide phosphate 4 Temozolomide 4 Nivolumab 4 Ipilimumab 4 Granulocyte Colony-Stimulating Factor 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡